BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14562285)

  • 1. Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma.
    Montironi R; Scarpelli M; Mazzucchelli R; Hamilton PW; Thompson D; Ranger-Moore J; Bostwick DG; Bartels PH
    Hum Pathol; 2003 Sep; 34(9):893-901. PubMed ID: 14562285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia.
    Montironi R; Thompson D; Scarpelli M; Mazzucchelli R; Peketi P; Hamilton PW; Bostwick DG; Bartels PH
    Mod Pathol; 2004 Aug; 17(8):928-37. PubMed ID: 15105811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.
    Montironi R; Scarpelli M; Lopez-Beltran A; Mazzucchelli R; Alberts D; Ranger-Moore J; Bartels HG; Hamilton PW; Einspahr J; Bartels PH
    Cell Oncol; 2007; 29(1):47-58. PubMed ID: 17429141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyometry detects subvisual differences in chromatin organisation state between non-recurrent and recurrent papillary urothelial neoplasms of low malignant potential.
    Scarpelli M; Montironi R; Tarquini LM; Hamilton PW; López Beltran A; Ranger-Moore J; Bartels PH
    J Clin Pathol; 2004 Nov; 57(11):1201-7. PubMed ID: 15509685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.
    Mazzucchelli R; Barbisan F; Stramazzotti D; Montironi R; Lopez-Beltran A; Scarpelli M
    Anal Quant Cytol Histol; 2005 Jun; 27(3):143-51. PubMed ID: 16121635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.
    Hartmann A; Moser K; Kriegmair M; Hofstetter A; Hofstaedter F; Knuechel R
    Am J Pathol; 1999 Mar; 154(3):721-7. PubMed ID: 10079249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma.
    Zizzi A; Montironi MA; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Paone N; Castellini P; Montironi R
    Diagn Pathol; 2013 Jul; 8():111. PubMed ID: 23819605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive papillary transitional-cell tumors. Karyometric and DNA-content analysis.
    Montironi R; Scarpelli M; Pisani E; Ansuini G; Marinelli F; Mariuzzi G
    Anal Quant Cytol Histol; 1985 Dec; 7(4):337-42. PubMed ID: 4091927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of the urothelial tumors of the urinary bladder.
    Helpap B; Köllermann J
    Hum Pathol; 2000 Jun; 31(6):745-50. PubMed ID: 10872670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall.
    Matoso A; Parimi V; Epstein JI
    Hum Pathol; 2021 Jul; 113():1-8. PubMed ID: 33887303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of morphometry in low grade papillary urothelial bladder neoplasms.
    Ramos D; Ruiz A; Morell L; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
    Anal Quant Cytol Histol; 2004 Oct; 26(5):285-94. PubMed ID: 15560535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary urothelial bladder carcinoma associated with osteoclast-like giant cells.
    Krüger S; Johannisson R; Kausch I; Feller AC
    Int Urol Nephrol; 2005; 37(1):61-4. PubMed ID: 16132761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential.
    Barbisan F; Mazzucchelli R; Santinelli A; Stramazzotti D; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2008; 21(3):615-23. PubMed ID: 18831929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of atypical papillary urothelial hyperplasia.
    Swierczynski SL; Epstein JI
    Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?
    Garbar C; Mascaux C
    Anal Quant Cytol Histol; 2011 Oct; 33(5):277-82. PubMed ID: 22611755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder.
    Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F
    J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary bladder biopsy with denuded mucosa: denuding cystitis-cytopathologic correlates.
    Parwani AV; Levi AW; Epstein JI; Ali SZ
    Diagn Cytopathol; 2004 May; 30(5):297-300. PubMed ID: 15108225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.